These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27541930)

  • 1. Modulation of Dopaminergic Pathways to Treat Erectile Dysfunction.
    Simonsen U; Comerma-Steffensen S; Andersson KE
    Basic Clin Pharmacol Toxicol; 2016 Oct; 119 Suppl 3():63-74. PubMed ID: 27541930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine D2-like receptor agonists induce penile erection in male rats: differential role of D2, D3 and D4 receptors in the paraventricular nucleus of the hypothalamus.
    Sanna F; Succu S; Hübner H; Gmeiner P; Argiolas A; Melis MR
    Behav Brain Res; 2011 Nov; 225(1):169-76. PubMed ID: 21784104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine and male sexual function.
    Giuliano F; Allard J
    Eur Urol; 2001 Dec; 40(6):601-8. PubMed ID: 11805404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open-label, uncontrolled dose-optimization study of sublingual apomorphine in erectile dysfunction.
    Mulhall JP; Bukofzer S; Edmonds AL; George M;
    Clin Ther; 2001 Aug; 23(8):1260-71. PubMed ID: 11558862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of dopamine receptors in the paraventricular nucleus of the hypothalamus of male rats induces penile erection and increases extra-cellular dopamine in the nucleus accumbens: Involvement of central oxytocin.
    Succu S; Sanna F; Melis T; Boi A; Argiolas A; Melis MR
    Neuropharmacology; 2007 Mar; 52(3):1034-43. PubMed ID: 17164075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PD-168077, a selective dopamine D4 receptor agonist, induces penile erection when injected into the paraventricular nucleus of male rats.
    Melis MR; Succu S; Mascia MS; Argiolas A
    Neurosci Lett; 2005 Apr; 379(1):59-62. PubMed ID: 15814200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sublingual apomorphine: new preparation. In erectile disorders: a narrow therapeutic margin.
    Prescrire Int; 2002 Jun; 11(59):76-9. PubMed ID: 12068841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on oral treatments for male erectile dysfunction.
    Kalsi JS; Kell PD
    J Eur Acad Dermatol Venereol; 2004 May; 18(3):267-74. PubMed ID: 15096134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral treatment of erectile dysfunction with apomorphine SL.
    Altwein JE; Keuler FU
    Urol Int; 2001; 67(4):257-63. PubMed ID: 11741126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging oral drugs for erectile dysfunction.
    Briganti A; Salonia A; Gallina A; Suardi N; Rigatti P; Montorsi F
    Expert Opin Emerg Drugs; 2004 May; 9(1):179-89. PubMed ID: 15155143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PIP3EA and PD-168077, two selective dopamine D4 receptor agonists, induce penile erection in male rats: site and mechanism of action in the brain.
    Melis MR; Succu S; Sanna F; Melis T; Mascia MS; Enguehard-Gueiffier C; Hubner H; Gmeiner P; Gueiffier A; Argiolas A
    Eur J Neurosci; 2006 Oct; 24(7):2021-30. PubMed ID: 17067298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Apomorphine and erectile dysfunction].
    Tan DQ; Yao Y; Zhang J
    Zhonghua Nan Ke Xue; 2007 Sep; 13(9):818-21. PubMed ID: 17929561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apomorphine-induced brain modulation during sexual stimulation: a new look at central phenomena related to erectile dysfunction.
    Montorsi F; Perani D; Anchisi D; Salonia A; Scifo P; Rigiroli P; Zanoni M; Heaton JP; Rigatti P; Fazio F
    Int J Impot Res; 2003 Jun; 15(3):203-9. PubMed ID: 12904807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apomorphine sublingual as primary or secondary treatment for erectile dysfunction in patients with spinal cord injury.
    Strebel RT; Reitz A; Tenti G; Curt A; Hauri D; Schurch B
    BJU Int; 2004 Jan; 93(1):100-4. PubMed ID: 14678378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine-oxytocin interactions in penile erection.
    Baskerville TA; Allard J; Wayman C; Douglas AJ
    Eur J Neurosci; 2009 Dec; 30(11):2151-64. PubMed ID: 20128851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central oxytocinergic neurotransmission: a drug target for the therapy of psychogenic erectile dysfunction.
    Melis MR; Argiolas A
    Curr Drug Targets; 2003 Jan; 4(1):55-66. PubMed ID: 12528990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central mechanisms regulating penile erection in conscious rats: the dopaminergic systems related to the proerectile effect of apomorphine.
    Hsieh GC; Hollingsworth PR; Martino B; Chang R; Terranova MA; O'Neill AB; Lynch JJ; Moreland RB; Donnelly-Roberts DL; Kolasa T; Mikusa JP; McVey JM; Marsh KC; Sullivan JP; Brioni JD
    J Pharmacol Exp Ther; 2004 Jan; 308(1):330-8. PubMed ID: 14569075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sublingual apomorphine for the treatment of erectile dysfunction.
    Mulhall JP
    Expert Opin Investig Drugs; 2002 Feb; 11(2):295-302. PubMed ID: 11829718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Erectile dysfunction].
    Isidori A; Aversa A; Fabbri A
    Recenti Prog Med; 1999; 90(7-8):396-402. PubMed ID: 10429521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central nervous system agents in the treatment of erectile dysfunction.
    Kendirci M; Walls MM; Hellstrom WJ
    Urol Clin North Am; 2005 Nov; 32(4):487-501, vii. PubMed ID: 16291040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.